全国服务咨询热线:

18438616290

Products产品中心
首页 > 产品中心 > 生化试剂 > 小分子化合物 > abs470279272,3-Butanedione 2-Monoxime 57-71-6

2,3-Butanedione 2-Monoxime 57-71-6

简要描述:2,3-Butanedione 2-Monoxime 57-71-6
2,3-Butanedione 2-Monoxime is an inhibitor of skeletal and cardiac muscle contraction.

  • 产品型号:abs47027927
  • 厂商性质:生产厂家
  • 更新时间:2026-01-07
  • 访  问  量:615

详细介绍

品牌absinCAS57-71-6
分子式C25H52NO4P纯度>99%
分子量461.66货号abs47027927
规格25mg供货周期现货
主要用途is an inhibitor of skeletal应用领域化工,生物产业,农林牧渔,制药/生物制药,综合

2,3-Butanedione 2-Monoxime 57-71-6

产品描述
描述
2,3-Butanedione 2-Monoxime is an inhibitor of skeletal and cardiac muscle contraction.
纯度
>99%
储存/保存方法
Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution.
基本信息
别名
2,3-丁烷二酮一肟;二乙酰一肟;NSC 660;NSC 116103
外观
白色至类白色结晶性粉末
可溶性/溶解性
10 mM in DMSO
生物活性
靶点
skeletal muscle myosin-II
In vitro(体外研究)
BDM inhibits skeletal muscle myosin-II, but it does not inhibit the ATPase activity of the other myosins. BDM has a broad effect on many non-myosin proteins (many uncharacterized), and thus should not be used in whole-cell experiments as a myosin inhibitor. BDM inhibits the L-type Ca2+-channel and reduces the opening probability, thereby increasing the closed time of this particular channel. BDM drives nonspecific protein dephosphorylation of many cellular proteins, including ion channels.
In vivo(体内研究)
BDM significant lowers the blood pressure in normo- and hypertensive rats. BDM has been shown to improve right atrial function in a porcine model of allogenic heart transplantation.
参考文献
参考文献
  • 1. Vyomesh Patel, et al. Cancer Res, 2002, 62(5), 1401-1409

  • 2. Momota H, et al. Cancer Res, 2005, 65(16), 7429-7435.

研究领域
研究领域
Metabolism
Drug DiscoverySmall Molecule DrugLead Compound Discovery
2,3-Butanedione 2-Monoxime 57-71-6温馨提示:本产品仅作科研实验使用,不支持临床等研究

产品咨询

留言框

  • 产品:

  • 您的单位:

  • 您的姓名:

  • 联系电话:

  • 常用邮箱:

  • 省份:

  • 详细地址:

  • 补充说明:

  • 验证码:

    请输入计算结果(填写阿拉伯数字),如:三加四=7
爱必信(上海)生物科技有限公司
地址:上海市浦东新区新浩路58号申江科创园18栋
邮箱:lanwu@univ-bio.com
传真:
关注我们
欢迎您关注我们的微信公众号了解更多信息:
欢迎您关注我们的微信公众号
了解更多信息